Sirio Europe invests in advanced manufacturing and green technologies
Manufacturing facility upgrades have substantially increased the CDMO’s production capacity and energy efficiency.
Sirio Europe — a European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO), part of the Sirio group — has completed a major overhaul of its Brandenburg site with advanced manufacturing and green technologies.
The improvements were implemented as part of Sirio Europe’s continuous efforts to further improve the quality and sustainability of manufacturing.
The company has installed new HVAC systems, which help to reduce the risk of product contamination.
Similarly, by installing individual drying chambers, the company can control the temperature of individual products, which is more energy-efficient and improves the softgel drying process.
In addition, adding a new vegetarian softgel manufacturing line, which transfers technology from Sirio’s Guangzhou plant, is a direct response to the growing demand for plant-based nutraceuticals.
In line with the company's commitment to increased sustainability, the site upgrades will be supported by an energy-efficient block heat and power station, which is estimated to increase power output by up to 50% through combined heat and power (CHP). The technology captures and recycles heat — otherwise lost as waste — into thermal energy to power the new manufacturing equipment.
Dominique Baum, Managing Director at Sirio Europe said that installing the heat block and power station not ony benefits the environment, it also makes good business sense: "For example, softgel production uses a lot of energy as strict parameters need to be adhered to; through CHP we can now manufacture softgels at a lower cost.”
The new plant upgrades form just a small part of wider drive at the Sirio Group to implement the most sustainable manufacturing processes of any nutraceutical CDMO globally; for example, the company exclusively sources ingredients from certified, sustainable suppliers, and are members of a number of certified sustainability groups, including the Friends of the Sea (part of the World Sustainability Organisation) and Marine Stewardship Council.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance